2024
Study Profile of the Tsuruoka Metabolomics Cohort Study (TMCS)
Harada S, Iida M, Miyagawa N, Hirata A, Kuwabara K, Matsumoto M, Okamura T, Edagawa S, Kawada Y, Miyake A, Toki R, Akiyama M, Kawai A, Sugiyama D, Sato Y, Takemura R, Fukai K, Ishibashi Y, Kato S, Kurihara A, Sata M, Shibuki T, Takeuchi A, Kohsaka S, Sawano M, Shoji S, Izawa Y, Katsumata M, Oki K, Takahashi S, Takizawa T, Maruya H, Nishiwaki Y, Kawasaki R, Hirayama A, Ishikawa T, Saito R, Sato A, Soga T, Sugimoto M, Tomita M, Komaki S, Ohmomo H, Ono K, Otsuka-Yamasaki Y, Shimizu A, Sutoh Y, Hozawa A, Kinoshita K, Koshiba S, Kumada K, Ogishima S, Sakurai-Yageta M, Tamiya G, Takebayashi T. Study Profile of the Tsuruoka Metabolomics Cohort Study (TMCS). Journal Of Epidemiology 2024, 34: 393-401. PMID: 38191178, PMCID: PMC11230875, DOI: 10.2188/jea.je20230192.Peer-Reviewed Original ResearchTsuruoka Metabolomics Cohort StudyCohort studyOngoing population-based cohort studyPrecision preventionPopulation-based cohort studySocial health determinantsHeated tobacco productsDisease sequelaeRisk stratificationAge-associated diseasesCancer incidenceDeep molecular profilingCardiovascular diseaseFunctional declinePhenotypic probeWomen's healthOngoing followHealth determinantsHealth statusDisease pathophysiologyPotential biomarkersTobacco productsMolecular profilingDiseaseHigh participation rates
2020
Association of Second-Generation Drug-Eluting Stent Length With 2-Year Adverse Clinical Outcomes Among Japanese Patients With Ischemic Heart Disease
Ejiri K, Sawano M, Numasawa Y, Noma S, Ito H, Fukuda K, Kohsaka S. Association of Second-Generation Drug-Eluting Stent Length With 2-Year Adverse Clinical Outcomes Among Japanese Patients With Ischemic Heart Disease. JAMA Network Open 2020, 3: e2012546. PMID: 32756926, PMCID: PMC7407091, DOI: 10.1001/jamanetworkopen.2020.12546.Peer-Reviewed Original Research